Francisco Aguilar, MD
Clinical Cardiac Electrophysiology · Hinsdale, ILNPI 1487637567
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 26.0% of the total.
Across 293 payments — averaging $155.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$12K
- Boehringer Ingelheim$12K
- Abbott$8K
- Lilly USA, LLC$6K
- Medtronic$5K
- Boston Scientific$2K
- plus $1K from 11 others
Across 10 payments — averaging $3147.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$28K
- Boston Scientific$3K
What the payments were for
- Consulting fees$5,00011%
- Speaking & faculty fees$22,53850%
- Travel & lodging$5,99113%
- Food & beverage$11,94126%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 23 | $11,839 |
| Boehringer Ingelheim | 16 | $11,592 |
| Abbott | 111 | $8,102 |
| Lilly USA, LLC | 9 | $5,563 |
| Medtronic(2 entities) | 43 | $5,422 |
| Boston Scientific | 61 | $1,894 |
| Cvrx, Inc. | 2 | $189 |
| Pfizer | 9 | $182 |
| Biosense Webster, Inc. | 2 | $177 |
| Cardiva Medical, Inc. | 4 | $153 |
| Amgen | 6 | $139 |
| AstraZeneca | 1 | $125 |
| Novartis | 2 | $46 |
| Stryker | 1 | $22 |
| Angiodynamics, Inc. | 1 | $19 |
| Cardinal Health 200 LLC | 1 | $14 |
| Impulse Dynamics (USA) Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$17,020
- LifeVest$11,214
- AVEIR$2,885
- ENSITE$981
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$779
- ENSITE PRECISION$426
- ARCTIC FRONT ADVANCE$287
- AFFERA MAPPING SYSTEM$191
- Unify Assura CRT Defibrillator$184
- Barostim Neo System$164
- GALLANT$159
- AMPLATZER AMULET$154
- CARDIOMEMS$146
- Advisor Catheter$143
- Micra$139
- Carto 3$127
- BRILINTA$125
- AGILIS$123
- GENERAL - THERAPIES$113
- Quadra Allure MP RF CRT Pacemkr$111
How this compares
$45,484 in reported general payments places this provider in the 70th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
See all clinical cardiac electrophysiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 761 | $795,256 |
| XareltoRivaroxaban | 143 | $147,640 |
| MultaqDronedarone Hcl | 72 | $108,689 |
| JardianceEmpagliflozin | 25 | $33,120 |
| EntrestoSacubitril/Valsartan | 33 | $32,870 |
| Flecainide Acetate | 251 | $9,528 |
| Dofetilide | 12 | $5,854 |
| Metoprolol Succinate | 360 | $4,943 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 21 | $4,803 |
| Digoxin | 114 | $4,611 |
| Mexiletine Hcl | 21 | $3,049 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 95 | $1,980 |
| Amiodarone Hcl | 89 | $1,887 |
| Carvedilol | 173 | $1,582 |
| SotalolSotalol Hcl | 99 | $1,567 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $182 | $795,256761 claims |
| Boehringer IngelheimJardiance | $11,592 | $33,12025 claims |
| NovartisEntresto | $46 | $32,87033 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
Other clinical cardiac electrophysiology in Hinsdale
- Andrew LawrenceHinsdale$40K
- Mansour RazminiaPalos Heights$927K
- Mark MetzlEvanston$799K
- Roderick TungChicago$795K
- Bradley KnightChicago$661K
- Gaurav UpadhyayChicago$593K
- Henry HuangGeneva$501K
- Kousik KrishnanNaperville$311K
- Hany DemoChicago$297K
- Cash CaseyElmhurst$287K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.